Shanghai - Delayed Quote CNY
BeOne Medicines Ltd. (688235.SS)
257.11
-10.29
(-3.85%)
At close: June 13 at 3:00:02 PM GMT+8
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 9 | 9 | 33 | 34 |
Avg. Estimate | 1.24B | 1.3B | 5.1B | 6.17B |
Low Estimate | 1.21B | 1.27B | 4.9B | 5.45B |
High Estimate | 1.27B | 1.34B | 5.3B | 7B |
Year Ago Sales | 929.17M | 1B | 3.81B | 5.1B |
Sales Growth (year/est) | 33.10% | 29.74% | 33.89% | 20.96% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
688235.SS | -- | -- | -- | -- |
S&P 500 | 13.13% | 2.41% | 7.55% | 14.06% |
Related Tickers
688180.SS Shanghai Junshi Biosciences Co., Ltd.
36.08
-6.65%
CYAD.BR Celyad Oncology SA
0.3960
-4.58%
NANOFH.HE Nanoform Finland Oyj
0.8700
+16.00%
FARON.HE Faron Pharmaceuticals Oy
2.6250
-3.85%
ACLX Arcellx, Inc.
66.00
-0.77%
VOR Vor Biopharma Inc.
0.1821
-12.03%
1801.HK INNOVENT BIO
80.700
-0.06%
NRIX Nurix Therapeutics, Inc.
11.93
-0.25%
9926.HK Akeso, Inc.
95.850
+0.42%
AFMDQ Affimed N.V.
0.0780
-4.88%